- Forums
- ASX - By Stock
- DXB
- Ann: FDA confirms Proteinuria as Primary Endpoint for US approval
DXB
dimerix limited
Add to My Watchlist
4.46%
!
58.5¢

Ann: FDA confirms Proteinuria as Primary Endpoint for US approval, page-4
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
58.5¢ |
Change
0.025(4.46%) |
Mkt cap ! $332.0M |
Open | High | Low | Value | Volume |
55.5¢ | 58.5¢ | 55.5¢ | $235.8K | 416.8K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 34682 | 57.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
58.5¢ | 107554 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 36402 | 0.575 |
4 | 136276 | 0.570 |
2 | 13423 | 0.565 |
3 | 19035 | 0.560 |
4 | 296664 | 0.555 |
Price($) | Vol. | No. |
---|---|---|
0.585 | 40858 | 3 |
0.590 | 119136 | 5 |
0.595 | 241699 | 8 |
0.600 | 185547 | 8 |
0.605 | 66249 | 4 |
Last trade - 10.25am 26/06/2025 (20 minute delay) ? |
Featured News
DXB (ASX) Chart |
The Watchlist
PTX
PRESCIENT THERAPEUTICS LIMITED
James McDonnell, CEO
James McDonnell
CEO
Previous Video
Next Video
SPONSORED BY The Market Online